Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Become a Member

Get access to more than 30 brands, premium video, exclusive content, events, mapping, and more.

Already have an account? Sign In

Brands

News

WTC Announces Anti-Doping Rule Violation Involving Tim Marr

The World Triathlon Corporation has announced that American Tim Marr has committed an anti-doping rule violation.

For access to all of our training, gear, and race coverage, plus exclusive training plans, FinisherPix photos, event discounts, and GPS apps, sign up for Outside+.

The World Triathlon Corporation has announced that American Tim Marr has committed an anti-doping rule violation. Marr was sentenced to a two-year period of ineligibility. Marr asked for a hearing and argued that he had inadvertently consumed the prescription amphetamine, Adderall. After the hearing, the American Arbitration Association/North American Court of Arbitration for Sport reduced Marr’s sentence to a time period of Aug. 13, 2010 to Feb. 22, 2011.

See the complete press release below:

Today, the World Triathlon Corporation (WTC) announced the imposition of an anti-doping sanction following the decision of an arbitrator from the American Arbitration Association/North American Court of Arbitration for Sport (AAA/CAS).   The AAA decision follows a hearing requested by triathlete, Timothy Marr, after the implementation of the required provisional suspension by the WTC finding that Marr had committed an anti-doping rule violation and would be subject to a two-year period of ineligibility and the disqualification of competitive results.

Marr, of Honolulu, Hawaii, provided his sample at the 2010 Ironman 70.3 Vineman, which took place on July 18.  The sample resulted in an adverse analytical finding for Amphetamine, which is in the class of stimulants prohibited in-competition on the World Anti-Doping Agency’s Prohibited List and by the World Triathlon Corporation Anti-Doping Rules (“WTC Rules”).

Marr exercised his right to a hearing to challenge the sanction required under the WTC Anti-Doping Rules given his claims that he had inadvertently consumed the prescription amphetamine, Adderall. The hearing was held before the AAA pursuant to the Association’s Supplementary Procedures for the Arbitration of Anti-Doping Rule Violations to ensure an independent review and decision of the facts surrounding this case.

The AAA Award confirmed Marr’s anti-doping rule violation while shortening his period of ineligibility from 24 months to a period running from August 13, 2010, the date the WTC imposed a provisional suspension, to the date of the Award, February 22, 2011. As a direct consequence, all of Marr’s results and prizes from the 2010 Ironman 70.3 Vineman are forfeited. Based on the AAA decision, Marr has now regained his eligibility.

In the AAA Award the arbitrator concluded, “the circumstances regarding the consumption of the Adderall were extremely unusual and fall under the category of exceptional,” and that the facts of the case “establish that Marr’s negligence was not significant.” Further the Arbitrator concluded that substance was “not taken with an intent to enhance sport performance.” Based on these findings, the arbitrator reduced Marr’s period of ineligibility while still finding that Marr was guilty of a doping violation under the WTC’s Anti-Doping Policy.

“This case illustrates the consequences of athletes failing to take every precaution to avoid any situation that may result in the ingestion of a prohibited substance,” said Kate Mittelstadt, director of anti-doping for WTC. “WTC will continue to work with athletes and race organizers to preserve the integrity of Ironman competition through anti-doping efforts and education.”